These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 9791144

  • 21. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA, Kline RL.
    J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
    [Abstract] [Full Text] [Related]

  • 22. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K, Gaudron P, Anders HJ, Weidemann F, Turschner O, Nahrendorf M, Ertl G.
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [Abstract] [Full Text] [Related]

  • 23. The Effect of the Angiotensin-Converting Enzyme Inhibitor on Bone Health in Castrated Hypertensive Rats Is Mediated via the Kinin-Kallikrein System.
    Zhang N, Huo Y, Yao C, Sun J, Zhang Y.
    J Renin Angiotensin Aldosterone Syst; 2022 Aug; 2022():9067167. PubMed ID: 35814865
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects.
    Azizi M, Guyene TT, Chatellier G, Ménard J.
    Clin Exp Hypertens; 1997 Aug; 19(5-6):937-51. PubMed ID: 9247766
    [Abstract] [Full Text] [Related]

  • 25. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
    Wagner J, Drab M, Bohlender J, Amann K, Wienen W, Ganten D.
    Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
    [Abstract] [Full Text] [Related]

  • 26. Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats.
    Takada J, Ibayashi S, Nagao T, Ooboshi H, Kitazono T, Fujishima M.
    Stroke; 2001 May; 32(5):1216-9. PubMed ID: 11340236
    [Abstract] [Full Text] [Related]

  • 27. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

  • 28. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.
    Jover B, Hérizi A, Mimran A.
    Hypertension; 1996 Jan; 27(1):79-84. PubMed ID: 8591893
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V, Fioretti S, Rigamonti A, Bonomo S, Manfredi B, Muller EE, Berti F, Rossoni G.
    J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
    [Abstract] [Full Text] [Related]

  • 30. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition.
    Bouaziz H, Joulin Y, Safar M, Benetos A.
    Br J Pharmacol; 1994 Nov; 113(3):717-22. PubMed ID: 7858859
    [Abstract] [Full Text] [Related]

  • 31. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC.
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
    Brouwers S, Smolders I, Massie A, Dupont AG.
    Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
    [Abstract] [Full Text] [Related]

  • 33. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S, Hahnel B, van der Giezen DM, Blezer EL, Goldschmeding R, Braam B, Kriz W, Koomans HA, Joles JA.
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [Abstract] [Full Text] [Related]

  • 34. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 35. Icatibant blocks but does not reverse ACE inhibitor renal effect in Goldblatt rabbit.
    Zimmerman BG.
    Clin Exp Hypertens; 2002 Jul 15; 24(5):325-32. PubMed ID: 12109773
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J, Koga T, Yamazaki T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1988 Jul 15; 292():203-22. PubMed ID: 3293542
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.